Hormone replacement therapy and venous thromboembolism

Journal of Steroid Biochemistry and Molecular Biology

Volumn 142, Issue , 2014, Pages 76-82

  Eisenberger, Andrew ^a   Westhoff, Carolyn ^a,b  

^a College of Physicians and Sur Columbia University Medical Center Division of Hematology/Oncology ^*  (United States)

^b Department of Medicine   (United States)

Author keywords

Deep venous thrombosis; Hormone replacement therapy; Venous thromboembolism Pulmonary embolism Factor V Leiden

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; ESTROGEN; GESTAGEN;

AGE; COMPARATIVE STUDY; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; POSTMENOPAUSE; REVIEW; RISK; RISK FACTOR; THERAPY EFFECT; THROMBOPHILIA; VENOUS THROMBOEMBOLISM; WEIGHT;

DEEP VENOUS THROMBOSIS; HORMONE REPLACEMENT THERAPY; VENOUS THROMBOEMBOLISM, PULMONARY EMBOLISM, FACTOR V LEIDEN;

AGE FACTORS; AGED; ESTROGEN REPLACEMENT THERAPY; FACTOR V; FEMALE; HUMANS; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDIES; RISK; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

EID: 84899986238     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2013.08.016     Document Type: Review

References (49)

1. E.T. Tyler Oral contraception and venous thrombosis JAMA 185 2 1963 131 132
2. W.H. Inman, M.P. Vessey, B. Westerholm, and A. Engelund Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs Br. Med. J. 2 5703 1970 203 209
3. R.A. Lobo Estrogen and the risk of coagulopathy Am. J. Med. 92 3 1992 283 285
4. The Boston Collaborative Drug Surveillance Program Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center N. Engl. J. Med. 290 1 1974 15 19
5. M. Devor, E. Barrett-Connor, M. Renvall, D. Feigal, and J. Ramsdell Jr. Estrogen replacement therapy and the risk of venous thrombosis Am. J. Med. 92 3 1992 275 282
6. S.J. Pitteri, S.M. Hanash, A. Aragaki, L.M. Amon, L. Chen, T. Busald Buson, S. Paczesny, H. Katayama, H. Wang, M.M. Johnson, Q. Zhang, M. McIntosh, P. Wang, C. Kooperberg, J.E. Rossouw, R.D. Jackson, J.E. Manson, J. Hsia, S. Liu, L. Martin, and R.L. Prentice Postmenopausal estrogen and progestin effects on the serum proteome Genome Med. 1 12 2009 121
7. L.E. Nachtigall, R.H. Nachtigall, R.D. Nachtigall, and E.M. Beckman Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems Obstet. Gynecol. 54 1 1979 74 79
8. The Writing Group for the PEPI Trial Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial JAMA 273 3 1995 199 208
9. H. Jick, L.E. Derby, M.W. Myers, C. Vasilakis, and K.M. Newton Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens Lancet 348 9033 1996 981 983
10. C. Varas-Lorenzo, L.A. Garcia-Rodriguez, C. Cattaruzzi, M.G. Troncon, L. Agostinis, and S. Perez-Gutthann Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population-based study in southern Europe Am. J. Epidemiol. 147 4 1998 387 390
11. N.L. Smith, S.R. Heckbert, R.N. Lemaitre, A.P. Reiner, T. Lumley, N.S. Weiss, E.B. Larson, F.R. Rosendaal, and B.M. Psaty Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis JAMA 292 13 2004 1581 1587
12. M. Canonico, E. Oger, G. Plu-Bureau, J. Conard, G. Meyer, H. Levesque, N. Trillot, M.T. Barrellier, D. Wahl, J. Emmerich, and P.Y. Scarabin Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study Circulation 115 7 2007 840 845
13. P.Y. Scarabin, E. Oger, and G. Plu-Bureau Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk Lancet 362 9382 2003 428 432
14. C. Straczek, E. Oger, M.B. Yon de Jonage-Canonico, G. Plu-Bureau, J. Conard, G. Meyer, M. Alhenc-Gelas, H. Levesque, N. Trillot, M.T. Barrellier, D. Wahl, J. Emmerich, and P.Y. Scarabin Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration Circulation 112 22 2005 3495 3500
15. E. Daly, M.P. Vessey, R. Painter, and M.M. Hawkins Case-control study of venous thromboembolism risk in users of hormone replacement therapy Lancet 348 9033 1996 1027
16. F. Grodstein, M.J. Stampfer, S.Z. Goldhaber, J.E. Manson, G.A. Colditz, F.E. Speizer, W.C. Willett, and C.H. Hennekens Prospective study of exogenous hormones and risk of pulmonary embolism in women Lancet 348 9033 1996 983 987
17. E. Daly, M.P. Vessey, M.M. Hawkins, J.L. Carson, P. Gough, and S. Marsh Risk of venous thromboembolism in users of hormone replacement therapy Lancet 348 9033 1996 977 980
18. J.D. Douketis, J.A. Julian, C. Kearon, D.R. Anderson, M.A. Crowther, S.M. Bates, M. Barone, F. Piovella, A.G. Turpie, S. Middeldorp, P. van Nguyen, P. Prandoni, P.S. Wells, M.J. Kovacs, M.R. MacGillavry, L. Costantini, and J.S. Ginsberg Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study J. Thromb. Haemost. 3 5 2005 943 948
19. T. Ohira, A.R. Folsom, M. Cushman, R.H. White, P.J. Hannan, W.D. Rosamond, and S.R. Heckbert Reproductive history, hormone replacement, and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology Br. J. Haematol. 149 4 2010 606 612
20. P.L. Lutsey, B.A. Virnig, S.B. Durham, L.M. Steffen, A.T. Hirsch, D.R. Jacobs, and A.R. Folsom Jr. Correlates and consequences of venous thromboembolism: the Iowa Women's Health Study Am. J. Public Health 100 8 2010 1506 1513
21. M. Cushman, L.H. Kuller, R. Prentice, R.J. Rodabough, B.M. Psaty, R.S. Stafford, S. Sidney, and F.R. Rosendaal Estrogen plus progestin and risk of venous thrombosis JAMA 292 13 2004 1573 1580
22. S. Hulley, C. Furberg, E. Barrett-Connor, J. Cauley, D. Grady, W. Haskell, R. Knopp, M. Lowery, S. Satterfield, H. Schrott, E. Vittinghoff, and D. Hunninghake Noncardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement study follow-up (HERS II) JAMA 288 1 2002 58 66
23. M.R. Vickers, A.H. MacLennan, B. Lawton, D. Ford, J. Martin, S.K. Meredith, B.L. DeStavola, S. Rose, A. Dowell, H.C. Wilkes, J.H. Darbyshire, and T.W. Meade Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women BMJ 335 7613 2007 239
24. E. Hoibraaten, E. Qvigstad, H. Arnesen, S. Larsen, E. Wickstrom, and P.M. Sandset Increased risk of recurrent venous thromboembolism during hormone replacement therapy - results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET) Thromb. Haemost. 84 6 2000 961 967
25. G.L. Anderson, M. Limacher, A.R. Assaf, T. Bassford, S.A. Beresford, H. Black, D. Bonds, R. Brunner, R. Brzyski, B. Caan, R. Chlebowski, D. Curb, M. Gass, J. Hays, G. Heiss, S. Hendrix, B.V. Howard, J. Hsia, A. Hubbell, R. Jackson, K.C. Johnson, H. Judd, J.M. Kotchen, L. Kuller, A.Z. LaCroix, D. Lane, R.D. Langer, N. Lasser, C.E. Lewis, J. Manson, K. Margolis, J. Ockene, M.J. O'Sullivan, L. Phillips, R.L. Prentice, C. Ritenbaugh, J. Robbins, J.E. Rossouw, G. Sarto, M.L. Stefanick, L. van Horn, J. Wactawski-Wende, R. Wallace, and S. Wassertheil-Smoller Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial JAMA 291 14 2004 1701 1712
26. M. Canonico, G. Plu-Bureau, G.D. Lowe, and P.Y. Scarabin Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis BMJ 336 7655 2008 1227 1231
27. O. Lidegaard, E. Lokkegaard, A.L. Svendsen, and C. Agger Hormonal contraception and risk of venous thromboembolism: national follow-up study BMJ 339 2009 b2890
28. J.D. Curb, R.L. Prentice, P.F. Bray, R.D. Langer, L. van Horn, V.M. Barnabei, M.J. Bloch, M.G. Cyr, M. Gass, L. Lepine, R.J. Rodabough, S. Sidney, G.I. Uwaifo, and F.R. Rosendaal Venous thrombosis and conjugated equine estrogen in women without a uterus Arch. Intern. Med. 166 7 2006 772 780
29. D. Grady, N.K. Wenger, D. Herrington, S. Khan, C. Furberg, D. Hunninghake, E. Vittinghoff, and S. Hulley Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The heart and estrogen/progestin replacement study Ann. Intern. Med. 132 9 2000 689 696
30. M.A. Allman-Farinelli Obesity and venous thrombosis: a review Semin. Thromb. Hemost. 37 8 2011 903 907
31. M. Canonico, V. Olie, L. Carcaillon, P. Tubert-Bitter, and P.Y. Scarabin Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: the ESTHER study Thromb. Haemost. 99 1 2008 246 248
32. G.D. Lowe, M.N. Upton, A. Rumley, A. McConnachie, D.S. O'Reilly, and G.C. Watt Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein - a cross-sectional population survey Thromb. Haemost. 86 2 2001 550 556
33. E. Oger, M. Alhenc-Gelas, K. Lacut, M.T. Blouch, N. Roudaut, V. Kerlan, M. Collet, J.F. Abgrall, M. Aiach, P.Y. Scarabin, and D. Mottier Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial Arterioscler. Thromb. Vasc. Biol. 23 9 2003 1671 1676
34. M.S. Post, M. Christella, L.G. Thomassen, M.J. van der Mooren, W.M. van Baal, J. Rosing, P. Kenemans, and C.D. Stehouwer Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women Arterioscler. Thromb. Vasc. Biol. 23 6 2003 1116 1121
35. P.Y. Scarabin, M. Alhenc-Gelas, G. Plu-Bureau, P. Taisne, R. Agher, and M. Aiach Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial Arterioscler. Thromb. Vasc. Biol. 17 11 1997 3071 3078
36. M. Canonico, A. Fournier, L. Carcaillon, V. Olie, G. Plu-Bureau, E. Oger, S. Mesrine, M.C. Boutron-Ruault, F. Clavel-Chapelon, and P.Y. Scarabin Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study Arterioscler. Thromb. Vasc. Biol. 30 2 2010 340 345
37. C. Renoux, S. Dell'Aniello, and S. Suissa Hormone replacement therapy and the risk of venous thromboembolism: a population-based study J. Thromb. Haemost. 8 5 2010 979 986
38. S. Sweetland, V. Beral, A. Balkwill, B. Liu, V.S. Benson, M. Canonico, J. Green, and G.K. Reeves Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study J. Thromb. Haemost. 10 11 2012 2277 2286
39. G. Lowe, M. Woodward, M. Vessey, A. Rumley, P. Gough, and E. Daly Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy Thromb. Haemost. 83 4 2000 530 535
40. F.R. Rosendaal, M. Vessey, A. Rumley, E. Daly, M. Woodward, F.M. Helmerhorst, and G.D. Lowe Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis Br. J. Haematol. 116 4 2002 851 854
41. E. Hoibraaten, E. Qvigstad, T.O. Andersen, M.C. Mowinckel, and P.M. Sandset The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism - results from a randomized, double-blind, clinical trial Thromb. Haemost. 85 5 2001 775 781
42. D.M. Herrington, E. Vittinghoff, T.D. Howard, D.A. Major, J. Owen, D.M. Reboussin, D. Bowden, V. Bittner, J.A. Simon, D. Grady, and S.B. Hulley Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease Arterioscler. Thromb. Vasc. Biol. 22 6 2002 1012 1017
43. J.D. Douketis, J.A. Julian, M.A. Crowther, C. Kearon, S.M. Bates, M. Barone, F. Piovella, S. Middeldorp, P. Prandoni, M. Johnston, L. Costantini, and J.S. Ginsberg The effect of prothrombotic blood abnormalities on risk of deep vein thrombosis in users of hormone replacement therapy: a prospective case-control study Clin. Appl. Thromb. Hemost. 17 6 2011 E106 E113
44. J. Rossouw, P. Bray, J. Liu, C. Kooperberg, J. Hsia, C. Lewis, M. Cushman, D. Bonds, S. Hendrix, G. Papanicolaou, T. Howard, and D. Herrington Estrogen receptor polymorphisms and the vascular effects of hormone therapy Arterioscler. Thromb. Vasc. Biol. 31 2 2011 464 469
45. M. Canonico, E. Bouaziz, L. Carcaillon, C. Verstuyft, A. Guiochon-Mantel, L. Becquemont, and P.Y. Scarabin Synergism between oral estrogen therapy and cytochrome P450 3A5*1 allele on the risk of venous thromboembolism among postmenopausal women J. Clin. Endocrinol. Metab. 93 8 2008 3082 3087
46. L.L. Schierbeck, L. Rejnmark, C.L. Tofteng, L. Stilgren, P. Eiken, L. Mosekilde, L. Kober, and J.E. Jensen Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial BMJ 345 2012 e6409
47. North American Menopause Society The 2012 hormone therapy position statement of: the North American Menopause Society Menopause 19 3 2012 257 271
48. C. Becattini, G. Agnelli, A. Schenone, S. Eichinger, E. Bucherini, M. Silingardi, M. Bianchi, M. Moia, W. Ageno, M.R. Vandelli, E. Grandone, and P. Prandoni Aspirin for preventing the recurrence of venous thromboembolism N. Engl. J. Med. 366 21 2012 1959 1967
49. T.A. Brighton, J.W. Eikelboom, K. Mann, R. Mister, A. Gallus, P. Ockelford, H. Gibbs, W. Hague, D. Xavier, R. Diaz, A. Kirby, and J. Simes Low-dose aspirin for preventing recurrent venous thromboembolism N. Engl. J. Med. 367 21 2012 1979 1987